Tamayo-Ordóñez María Concepción, Rosas-García Ninfa María, Ayil-Gutiérrez Benjamín Abraham, Bello-López Juan Manuel, Tamayo-Ordóñez Francisco Alberto, Anguebes-Franseschi Francisco, Damas-Damas Siprian, Tamayo-Ordóñez Yahaira de Jesús
Laboratorio de Ingeniería Genética, Departamento de Biotecnología, Facultad de Ciencias Químicas, Universidad Autónoma de Coahuila, Saltillo 25280, Coahuila, Mexico.
Laboratorio de Biotecnología Ambiental del Centro de Biotecnología Genómica, Instituto Politécnico Nacional, Reynosa 88710, Tamaulipas, Mexico.
Pathogens. 2023 Sep 21;12(9):1185. doi: 10.3390/pathogens12091185.
SARS-CoV-2 was the cause of the global pandemic that caused a total of 14.9 million deaths during the years 2020 and 2021, according to the WHO. The virus presents a mutation rate between 10-5 and 10-3 substitutions per nucleotide site per cell infection (s/n/c). Due to this, studies aimed at knowing the evolution of this virus could help us to foresee (through the future development of new detection strategies and vaccines that prevent the infection of this virus in human hosts) that a pandemic caused by this virus will be generated again. In this research, we performed a functional annotation and identification of changes in Nsp (non-structural proteins) domains in the coronavirus genome. The comparison of the 13 selected coronavirus pangenomes demonstrated a total of 69 protein families and 57 functions associated with the structural domain's differentials between genomes. A marked evolutionary conservation of non-structural proteins was observed. This allowed us to identify and classify highly pathogenic human coronaviruses into alpha, beta, gamma, and delta groups. The designed Nsp cluster provides insight into the trajectory of SARS-CoV-2, demonstrating that it continues to evolve rapidly. An evolutionary marker allows us to discriminate between phylogenetically divergent groups, viral genotypes, and variants between the alpha and betacoronavirus genera. These types of evolutionary studies provide a window of opportunity to use these Nsp as targets of viral therapies.
根据世界卫生组织的数据,严重急性呼吸综合征冠状病毒2(SARS-CoV-2)是导致全球大流行的病原体,在2020年至2021年期间共造成1490万人死亡。该病毒的突变率为每个细胞感染事件中每个核苷酸位点10-5至10-3个替换(s/n/c)。因此,旨在了解该病毒进化的研究可以帮助我们预见(通过未来开发新的检测策略和预防该病毒在人类宿主中感染的疫苗)由该病毒引发的大流行是否会再次发生。在这项研究中,我们对冠状病毒基因组中的非结构蛋白(Nsp)结构域进行了功能注释和变化鉴定。对13个选定的冠状病毒泛基因组的比较显示,共有69个蛋白家族和57种功能与基因组之间结构域的差异相关。观察到非结构蛋白具有显著的进化保守性。这使我们能够将高致病性人类冠状病毒分为α、β、γ和δ组。所设计的Nsp聚类提供了对SARS-CoV-2进化轨迹的洞察,表明它仍在快速进化。一个进化标记使我们能够区分系统发育上不同的组、病毒基因型以及α冠状病毒属和β冠状病毒属之间的变体。这类进化研究为将这些Nsp用作病毒治疗靶点提供了机会之窗。